How Long Does Meth Stay in Your System?

Methamphetamine stays in your system for up to 3 days in a standard urine drug test, according to Mayo Clinic Laboratories. Blood and saliva windows close faster, while hair testing looks back roughly 90 days.

How long meth stays detectable is not the same question as how long it keeps working. Your liver converts part of every dose into amphetamine, and tests read both compounds.

Dose, how often someone uses, kidney function, and urine acidity all move the number. Two people who used the same amount on the same night can test differently.

Understanding which test is being used, and what threshold it applies, explains most of the confusion.

Key Takeaways

• Urine is the default test and the shortest answer. Mayo Clinic Laboratories lists methamphetamine as detectable in urine up to 3 days at a 25 ng/mL limit of quantitation.
• The liver converts methamphetamine into amphetamine, so a laboratory report after methamphetamine use normally names both compounds.
• Urine chemistry moves the window more than most people expect. Methamphetamine leaves the body mainly through the kidneys, and alkaline urine markedly prolongs its half-life while acidic urine speeds elimination.
• SAMHSA’s 2024 National Survey on Drug Use and Health reports 0.8 percent of people aged 12 or older, roughly 2.4 million, used methamphetamine last year.
• No medication is approved to treat the underlying disorder. The 2024 ASAM/AAAP clinical practice guideline on stimulant use disorder builds its recommendations around behavioral treatment because no medication carries FDA approval for this condition.

What Does the Body Turn Methamphetamine Into?

The liver converts methamphetamine into amphetamine, and a urine panel reads both compounds because both remain active.

The Two Forms of Methamphetamine

• d-methamphetamine drives the effects people seek: dextromethamphetamine is the pharmacologically active isomer in the United States.
• l-methamphetamine sits in ordinary medicine cabinets: levomethamphetamine is a far weaker stimulant that appears in some over-the-counter nasal decongestant inhalers as a vasoconstrictor.
• Standard screens cannot tell them apart: Mayo Clinic Laboratories notes these tests do not differentiate dextro isomers from the racemic mixtures found in street supply, so enantiomer questions belong to confirmatory testing.

What Happens During Metabolism

• The liver handles most of the work: hepatic metabolism proceeds through aromatic hydroxylation, dealkylation, and deamination, with CYP2D6 performing 4-hydroxylation to pholedrine.
• Methamphetamine interferes with its own clearance: the drug also acts as a competitive inhibitor of CYP2D6, and inhibitors such as fluoxetine or paroxetine raise systemic levels further.
• Genetics change the numbers: CYP2D6 variation produces poor, intermediate, extensive, and ultrarapid metabolizer phenotypes, with roughly 5 to 10 percent of people of European ancestry classified as poor metabolizers.
• Amphetamine is the metabolite that matters for testing: the conversion means both compounds appear on a urine panel, which is how laboratories confirm methamphetamine as the source.
• Metabolite targeting differs across drug classes: stimulant drug classes differ here from long-acting benzodiazepines and semi-synthetic opioids.

What Determines How Long Meth Stays in Your System?

Dose, frequency, route, kidney and liver function, CYP2D6 phenotype, and urine pH together determine how long methamphetamine remains detectable in any given person.

Kidney Clearance and Urine pH

• Excretion runs mainly through the kidneys: methamphetamine leaves the body primarily in urine, and the rate of that excretion depends directly on urinary pH.
• Alkaline urine stretches the window: alkalinization slows renal clearance and markedly prolongs the drug’s half-life, intensifying and extending exposure.
• Acidic urine shortens it: acidifying conditions accelerate elimination, which is also why clinicians managing methamphetamine-related rhabdomyolysis avoid urinary alkalinization.
• Most of a dose clears within a day: approximately 62 percent of an oral dose leaves in urine within the first 24 hours, about a third of it as unchanged drug.

Dose, Frequency, and Route of Use

• Repeated use raises the starting point: Mayo Clinic Laboratories states plainly that actual detection time depends on dose, frequency of use, and individual metabolism, which is why chronic use extends beyond published single-dose figures.
• Route changes onset rather than total clearance: smoking and injection produce effects within roughly 5 minutes while oral use takes longer, though the elimination pathway is the same.
• Effects and detection follow different clocks: euphoria typically lasts 6 to 12 hours, which is a fraction of the period a laboratory can still identify the drug.

Organ Function and Individual Variation

• Impaired kidneys allow accumulation: methamphetamine and its metabolites are renally excreted, and moderate to severe renal impairment permits build-up.
• Liver impairment slows conversion: because metabolism runs partly through CYP2D6, reduced hepatic function extends exposure to both methamphetamine and amphetamine.
• Poor metabolizers behave differently: higher plasma concentrations in poor CYP2D6 metabolizers carry an increased risk of cardiovascular and neurotoxic effects alongside altered clearance.

How Long Does Meth Stay in Urine, Blood, Saliva, and Hair?

Methamphetamine remains detectable in urine for up to 3 days, in oral fluid for roughly 24 to 48 hours, in blood for a matter of hours, and in hair for approximately 90 days.

Detection Windows by Test Type

Test type	Detection window	What it establishes	Source
Urine	Up to 3 days at 25 ng/mL limit of quantitation	Exposure within the preceding 2 to 3 days	Mayo Clinic Laboratories
Oral fluid (saliva)	Approximately 24 to 48 hours	Recent use, detectable soon after ingestion	Quest Diagnostics
Blood	Hours, shortest of the four	Active drug level and current impairment	Verstraete, 2004
Hair	Up to approximately 90 days	Pattern of repetitive use, not recent use	Quest Diagnostics

What Each Test Is Actually For

• Urine remains the default for treatment and workplace monitoring: it offers the broadest testing options and the best balance between window length and ease of collection.
• Oral fluid is the recent-use test: collection can be directly observed, which reduces tampering, though windows are shorter and drug concentrations lower.
• Blood answers questions about impairment: its very short window suits emergency, forensic, and impaired-driving settings rather than routine screening.
• Hair answers questions about history: a hair test provides an approximate three-month record of repetitive use and is poorly suited to identifying a single recent episode.

Hour by Hour After the Last Dose

1. 5 to 30 minutes: effects begin, with the fastest onset following injection or smoking.
2. Within the first 1 to 2 hours: oral fluid becomes positive, since methamphetamine appears in saliva shortly after use.
3. 6 to 12 hours: euphoric and stimulant effects fade while the drug remains fully detectable.
4. 0 to 24 hours: roughly 62 percent of an oral dose leaves in urine, about one third of it unchanged.
5. 24 to 48 hours: the oral fluid window closes for most people.
6. 48 to 72 hours: urine typically still reads positive at a 25 ng/mL limit of quantitation.
7. After 72 hours: urine usually turns negative following single use, while heavy or repeated use extends this further.
8. Up to 90 days: hair testing continues to reflect a pattern of repeated use.

Nursing Observations From Detox Intake at New Spirit Recovery

• Intake testing sits alongside clinical assessment: Cynthia Prieto, Director of Nursing, notes that a detection window shows when someone last used, while symptom presentation shows what the body is doing now.
• Round-the-clock nursing covers the gap after testing: the medically supervised detoxification program runs 7 to 10 days on average, extending to 10 to 21 days when medical necessity requires.
• Staffing density shapes what gets noticed: an approximately 1:1 staff-to-client ratio means changes in sleep, appetite, and mood register early rather than at the next scheduled check.

Meth Drug Test Cutoff Levels and Confirmatory Testing

Federal workplace testing applies an initial immunoassay cutoff of 500 ng/mL for amphetamines and a confirmatory cutoff of 250 ng/mL, and a specimen must exceed both thresholds before a laboratory reports it as positive.

The Two-Step Testing Process

• The first test is designed to be sensitive rather than specific: an initial immunoassay screen separates clear negatives from specimens that need closer examination.
• The second test is designed to be definitive: confirmation runs on gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry, which identify specific molecules rather than drug classes.
• Both thresholds must be cleared: a specimen below either the screening or the confirmatory cutoff is reported negative, which means trace quantities of drug can be present in a negative result.
• Cutoffs were lowered from earlier standards: SAMHSA reduced the amphetamine and methamphetamine initial cutoff from 1,000 to 500 ng/mL and the confirmatory cutoff from 500 to 250 ng/mL.

Why Confirmation Looks for Amphetamine Too

• The metabolite corroborates the parent drug: because methamphetamine converts to amphetamine, confirmation of a methamphetamine result normally expects the corresponding metabolite to be present.
• The reverse conversion does not happen: Mayo Clinic Laboratories states that amphetamine is not metabolized to methamphetamine, so amphetamine present without methamphetamine indicates amphetamine was the primary drug used.
• This single asymmetry resolves most disputed results: the presence or absence of the parent compound is what separates illicit methamphetamine use from prescription amphetamine use on a laboratory report.

Meth vs Prescription Amphetamines on a Drug Test

Prescription amphetamines and illicit methamphetamine both trigger the amphetamine class on an immunoassay screen, but confirmatory testing separates them by looking for methamphetamine itself.

How the Two Results Differ

Criterion	Illicit methamphetamine	Prescription amphetamine
Immunoassay screen	Positive for amphetamine class	Positive for amphetamine class
Compounds on confirmation	Methamphetamine and amphetamine	Amphetamine without methamphetamine
Interpretation	Methamphetamine is the drug used	Amphetamine is the primary drug used
Urine detection time	Up to 3 days	Up to 3 days

Substances That Legitimately Produce a Methamphetamine Result

• Three medications metabolize into methamphetamine directly: Mayo Clinic Laboratories identifies selegiline, femprofazone, and benzphetamine as agents metabolized to both methamphetamine and amphetamine.
• One metabolizes to amphetamine only: clobenzorex breaks down to amphetamine without producing methamphetamine.
• Decongestants persist longer than the drug itself: ephedrine and pseudoephedrine remain detectable for up to 5 days, longer than the 3-day methamphetamine window, and standard tests do not distinguish between them.
• MDMA follows its own pathway: 3,4-methylenedioxymethamphetamine metabolizes to 3,4-methylenedioxyamphetamine, with both detectable for approximately 2 days.
• Disclosure before testing settles this: anyone taking a prescription in these categories should report it to the medical review officer rather than contest the result afterward.

Clinical Assessment When Test Results Are Ambiguous at New Spirit Recovery

• A laboratory result is one input among several: Sean O’Neill, LMFT, Clinical Director, notes that a positive amphetamine screen calls for full clinical evaluation whether or not the person holds a prescription.
• Prescription stimulant use and illicit use are not mutually exclusive: the clinical team assesses prescription stimulant misuse and methamphetamine use as separate questions during the same intake evaluation.
• Assessment happens before program assignment: real-time insurance verification, clinical evaluation, medical assessment, and safety planning all precede placement into residential treatment.

What a Positive Meth Test Does and Does Not Tell You

A confirmed methamphetamine result establishes recent exposure and nothing more, which is why interpretation belongs to a clinician rather than to the panel.

What a Confirmed Result Establishes

• Exposure inside a defined window: a urine result above the confirmatory cutoff indicates use in the preceding 2 to 3 days.
• Which compound was taken: methamphetamine present alongside amphetamine separates illicit use from prescription amphetamine use.
• That a threshold was crossed: the specimen exceeded both the screening and confirmatory cutoffs, which is a laboratory fact rather than a clinical conclusion.

What a Result Cannot Establish

• Dose or frequency: concentration does not indicate how much was used, and chronic use extends the window well past single-dose figures.
• Current impairment: euphoric effects last 6 to 12 hours while detection runs for days, so a positive test says nothing about present function.
• Whether a use disorder exists: a single result cannot diagnose stimulant use disorder, which requires assessment against DSM-5-TR criteria.
• Whether organ damage has occurred: testing does not detect severe tooth degeneration or methamphetamine-induced psychosis, which require separate clinical evaluation.

When Meth Use Becomes a Medical Emergency

• Seek emergency care for altered mental status: confusion, severe agitation, or loss of consciousness after use requires immediate medical attention.
• Seek emergency care for chest pain or breathing difficulty: these can signal acute coronary syndrome, arrhythmia, or myocardial infarction.
• Seek emergency care for very high body temperature: core temperatures above 40.5 degrees Celsius call for rapid cooling.
• Seek emergency care for seizures: seizures occur at high doses and are managed with benzodiazepines as first-line treatment.
• Seek emergency care for suicidal thoughts: methamphetamine is a strong independent predictor of suicidality, and psychiatric assessment during withdrawal is standard practice.

When a Result Warrants Clinical Assessment

• The Drug Abuse Screening Test (DAST-10) provides a brief starting point: this 10-item questionnaire scores drug-related problems from 0 to 10, with higher totals indicating greater severity.
• DSM-5-TR criteria determine the diagnosis: stimulant use disorder is assessed against 11 criteria, with severity graded by how many are met rather than by quantity used.
• Withdrawal is prolonged rather than dangerous: symptoms can persist for months after cessation, which distinguishes stimulant recovery from opioid or alcohol detox.

Treatment After a Confirmed Methamphetamine Result

Behavioral therapy leads methamphetamine treatment because no medication holds FDA approval for stimulant use disorder.

Why Behavioral Treatment Leads

• Contingency management holds the strongest evidence base: reinforcing documented abstinence with incentives has produced reductions in use and longer treatment retention for stimulant use disorder specifically.
• The Matrix Model was built for this population: developed by Richard A. Rawson and colleagues at UCLA, this structured protocol combines relapse prevention, family education, and social support.
• No approved medication exists for the disorder itself: the 2024 ASAM and AAAP clinical practice guideline on stimulant use disorder centers behavioral treatment for this reason.
• Co-occurring conditions are treated on their own terms: depression, anxiety, bipolar disorder, and post-traumatic stress disorder are addressed within an integrated plan.

Emerging and Investigational Options

• Combination naltrexone and bupropion is under investigation: this off-label pairing has been studied for methamphetamine use disorder and remains investigational rather than approved.
• Repetitive transcranial magnetic stimulation is being trialled: rTMS is under study for stimulant craving reduction and is not FDA-approved for this indication.
• State policy is expanding contingency management access: California became the first state approved to cover contingency management through Medicaid, delivered as the Recovery Incentives Program for Medi-Cal beneficiaries.

Where Assessment Happens

• A positive test is a referral point, not a treatment plan: clinical evaluation and medical assessment establish level of care.
• Signs and long-term effects are assessed separately: the broader picture of methamphetamine dependence covers symptoms and consequences a test cannot show.
• Medical stabilization may come first: withdrawal that requires monitoring is stabilized before ongoing treatment begins.

Treatment at New Spirit Recovery

New Spirit Recovery provides medically supervised detoxification and residential treatment for methamphetamine addiction across three licensed locations in the Los Angeles area.

Medical Detoxification

• Length is set by medical necessity: detoxification averages 7 to 10 days and extends to 10 to 21 days when the medical team determines it is warranted.
• Supervision is continuous: 24-hour medical and nursing coverage operates alongside physician oversight, with registered alcohol and drug technicians staffing all shifts.
• Medical review is scheduled, not incidental: physician consultations occur at minimum weekly, with Medical Director and Nurse Practitioner oversight of all medication management.

Residential Treatment

• Programming runs seven days a week: residential clients participate in 6 hours of daily programming, typically as part of a 35-day overall course of treatment.
• Group work covers the specific mechanics of stimulant relapse: daily groups include relapse prevention, trigger identification, distress tolerance training, step work, CBT and DBT groups, expressive arts therapy, and Rock to Recovery sessions.
• Individual therapy is guaranteed and often increased: clients receive weekly individual sessions at minimum, supplemented according to acuity and clinical need.
• Settings are small by design: the Tarzana, Northridge, and Encino locations operate at 3 to 12 beds each rather than at the scale of larger facilities.

The Rewired Curriculum

• Rewired is specific to New Spirit Recovery: Erica Spiegelman, co-founder and Rewired curriculum creator, built the trigger module because people leaving detox count abstinence days while overlooking the situations preceding past use.
• The curriculum runs across ten modules: content covers emotional regulation, stress management, self-awareness, trigger identification, healthy boundaries, and personal accountability.
• Skills work runs in parallel with clinical care: Rewired groups sit alongside the evidence-based modalities rather than substituting for them.

Step-Down and Continuing Care

• Care steps down rather than stopping: step-down programming moves through partial hospitalization with sober living coordination, intensive outpatient, and outpatient levels.
• Community integration is built into the week: weekend programming emphasizes community reintegration in line with the fourth dimension of the ASAM criteria, including outside Alcoholics Anonymous, Narcotics Anonymous, and Dharma Recovery meetings.
• Family involvement runs throughout: family therapy, family education, and ongoing family sessions continue across the treatment stay rather than being confined to a single scheduled weekend.

Frequently Asked Questions

What drug stays in your system the longest?

Among commonly tested substances, chronic cannabis use produces the longest urine detection window, extending several weeks. For methamphetamine specifically, hair testing offers the longest look back at roughly 90 days, while urine detection runs up to 3 days. The specimen type matters more than the drug in most comparisons.

How long can a laboratory detect meth in urine?

Mayo Clinic Laboratories lists methamphetamine urine detection at up to 3 days using a 25 ng/mL limit of quantitation, and interprets a positive result as exposure in the preceding 2 to 3 days. Heavy or frequent use extends this. Reference laboratories publish slightly different figures because cutoff concentrations and assay sensitivity vary between them.

What can make you test positive for methamphetamine?

Selegiline, femprofazone, and benzphetamine all metabolize into methamphetamine and amphetamine, producing genuine positives that do not reflect illicit use. Ephedrine and pseudoephedrine remain detectable up to 5 days and are not differentiated from each other on standard tests. Reporting current medications to the medical review officer before testing prevents most disputes.

What are the cutoff levels for a meth drug test?

Federal workplace testing uses a 500 ng/mL initial immunoassay cutoff for amphetamines and a 250 ng/mL confirmatory cutoff. Both thresholds must be exceeded before a laboratory reports a positive result. These figures were reduced from previous levels of 1,000 ng/mL and 500 ng/mL respectively.

Does Adderall show up as meth on a drug test?

Prescription amphetamines trigger the amphetamine class on an initial screen but do not produce methamphetamine on confirmation. Amphetamine is not metabolized into methamphetamine, so amphetamine detected without methamphetamine indicates amphetamine was the primary drug used. Confirmatory testing is what makes this distinction.

How long does a meth comedown last?

Acute comedown symptoms including fatigue, increased appetite, low mood, and heavy sleep typically occupy the first several days after use stops. Broader withdrawal symptoms can persist for months, particularly following heavy long-term use. This extended timeline is why stimulant recovery planning extends well past the detox period.

Is meth detectable in breast milk?

Methamphetamine is excreted into breast milk, and both methamphetamine and its amphetamine metabolite have been detected in breast milk and in infant serum after maternal use. Serious effects including irritability, poor feeding, and agitation have been reported in nursing infants. Breastfeeding should be avoided, and a clinician should be consulted directly.

Can you flush meth out of your system faster?

No commercial detox product, water loading, or supplement reliably shortens the detection window, and several carry their own risks. Elimination depends on kidney function, urine pH, and CYP2D6 metabolism, none of which respond usefully to consumer products. Attempting to dilute a specimen is also detectable through specimen validity testing.

References

1. Patel, P., & Saadabadi, A. (2025). Methamphetamine. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK535356/
2. Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60). Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases
3. Mayo Clinic Laboratories. (2026). Amphetamine-type stimulants (ATS). Drug testing reference guide. APA citation only.
4. Clinical Guideline Committee Members, ASAM Team, AAAP Team, & IRETA Team. (2024). The ASAM/AAAP clinical practice guideline on the management of stimulant use disorder. Journal of Addiction Medicine, 18(1S Suppl 1), 1-56.
5. Verstraete, A. G. (2004). Detection times of drugs of abuse in blood, urine, and oral fluid. Therapeutic Drug Monitoring, 26(2), 200-205.
6. de la Torre, R., Yubero-Lahoz, S., Pardo-Lozano, R., & Farré, M. (2012). MDMA, methamphetamine, and CYP2D6 pharmacogenetics: What is clinically relevant? Frontiers in Genetics, 3, 235.
7. Robbins, B., Carpenter, R. E., Long, M., & Perry, J. (2022). A human oral fluid assay for D- and L-isomer detection of amphetamine and methamphetamine using liquid-liquid extraction. Journal of Analytical Methods in Chemistry, 2022, 4819599.
8. Huang, W., Czuba, L. C., & Isoherranen, N. (2020). Mechanistic PBPK modeling of urine pH effect on renal and systemic disposition of methamphetamine and amphetamine. Journal of Pharmacology and Experimental Therapeutics, 373(3), 488-501.
9. Substance Abuse and Mental Health Services Administration. (2024). Regulatory program updates: Mandatory guidelines for federal workplace drug testing programs. Drug Testing Advisory Board. https://www.samhsa.gov/sites/default/files/meeting/documents/regulatory-program-updates-mandatory-guidelines-dtab.pdf
10. Quest Diagnostics. (2023). Hair drug testing: Frequently asked questions. Employer Solutions. APA citation only.
11. California Department of Health Care Services. (2025). Recovery Incentives Program: California’s contingency management benefit. APA citation only.